Promoter region methylation analysis of glutathione S-transferase p1 gene in prostate carcinoma

Academic Journal of Second Military Medical University

Volumn 29, Issue 7, 2008, Pages 762-767

  Du, Wen Bin ^a   Hou, Jian Guo ^a   Wu, Qi ^a   Chang, Wen Jun ^b   Zhai, Yu Jia ^b   Lin, Li Ping ^b   Cao, Ting Hu ^a   Sun, Jun Wen ^b   Zhang, Hong Wei ^a   Cao, Guang Wen ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Glutathione transferase; Methylation; Promoter regions; Prostatic neoplasms

Indexed keywords

GLUTATHIONE TRANSFERASE P1; MOLECULAR MARKER; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EARLY DIAGNOSIS; GENE SEQUENCE; MOLECULAR CLONING; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; SENSITIVITY AND SPECIFICITY;

EID: 48449092021     PISSN: 0258879X     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1008.2008.00762     Document Type: Article

References (12)

1. Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970-2002[J]. JAMA,2005, 294:1255-1259.
2. Lecomte T, Landi B, Beaune P, Laurent-Puig P, Loriot M A. Glutathione S-transferase P1 polymorphism (Ile105Val) predicts cumulative neuropathy in patients receiving oxaliplatin-based chemotherapy[J]. Clin Cancer Res,2006,12:3050-3056.
3. Millar D S, Kow K K, Paul C L, Russell P J, Molloy P L, Clark S J. Detailed methylation analysis of the glutathione S-transferase π (GSTP1) gene in prostate cancer[J]. Oncogene, 1999, 18:1313-1324.
4. Schamhart D, Swinnen J, Kurth K R, Westerhof A, Kusters R, Borchers H, et al. Numeric definition of the clinical performance of the nested reverse transcription-PCR for detection of hematogenous epithelial cells and correction for specific mRNA of non-target cell origin as evaluated for prostate cancer cells[J]. Clin Chem,2003,49:1458-1466.
5. Grunau C, Clark S J, Rosenthal A. Bisulfite genomic sequencing: systematic investigation of critical experimental parameters[J]. Nucleic Acids Res,2001,29:E655.
6. Perry A S, Foley R, Woodson K, Lawler M. The emerging roles of DNA methylation in the clinical management of prostate cancer[J]. Endocr Relat Cancer,13:357-377.
7. Lee W H, Morton R A, Epstein J I, Brooks J D, Campbell P A, Bova G S, et al. Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis[J]. Proc Natl Acad Sci USA, 1994,91:11733-11737.
8. Lin X, Tascilar M, Lee W H, Vles W J, Lee B H, Veeraswamy R, et al. GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells[J]. Am J Pathol,2001,159:1815-1826.
9. Chinese source.
10. Rouprêt M, Hupertan V, Yates D R, Catto J W, Rehman I, Meuth M, et al. Molecular detection of localized prostate cancer using quantitative methylation-specific PCR on urinary cells obtained following prostate massage[J]. Clin Cancer Res, 2007, 13:1720-1725.
11. Goessl C, Muller M, Heicappell R, Krause H, Miller K. DNA-based detection of prostate cancer in blood, urine, and ejaculates [J]. Ann N Y Acad Sci,2001,945:51-58.
12. Chinese source.